Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- Advanced Bile Duct Carcinoma
- Advanced Breast Carcinoma
- Advanced Cervical Carcinoma
- Advanced Endometrial Carcinoma
- Advanced Esophageal Carcinoma
- Advanced Gastric Carcinoma
- Advanced Head and Neck Carcinoma
- Advanced Lung Non-Small Cell Carcinoma
- Advanced Lung Small Cell Carcinoma
- Advanced Malignant Solid Neoplasm
- Advanced Ovarian Carcinoma
- Advanced Penile Carcinoma
- Advanced Pleural Malignant Mesothelioma
- Advanced Urothelial Carcinoma
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8
- Clinical Stage III Gastric Cancer AJCC v8
- Clinical Stage IV Gastric Cancer AJCC v8
- Stage III Cervical Cancer AJCC v8
- Stage III Distal Bile Duct Cancer AJCC v8
- Stage III Intrahepatic Bile Duct Cancer AJCC v8
- Stage III Lung Cancer AJCC v8
- Stage III Ovarian Cancer AJCC v8
- Stage III Penile Cancer AJCC v8
- Stage III Pleural Diffuse Malignant Mesothelioma AJCC v8
- Stage IV Cervical Cancer AJCC v8
- Stage IV Distal Bile Duct Cancer AJCC v8
- Stage IV Intrahepatic Bile Duct Cancer AJCC v8
- Stage IV Lung Cancer AJCC v8
- Stage IV Ovarian Cancer AJCC v8
- Stage IV Penile Cancer AJCC v8
- Stage IV Pleural Diffuse Malignant Mesothelioma AJCC v8
- Triple-Negative Breast Carcinoma
- Unresectable Urothelial Carcinoma
Interventions
- DRUG: Cisplatin
- DRUG: Elimusertib
- DRUG: Gemcitabine Hydrochloride
Sponsor
National Cancer Institute (NCI)